ORBIS and Alcon Call Attention to the Aging Eye
... three-quarters of them could
have avoided their blindness
if they had been properly diagnosed or
... States on the need to eliminate avoidable blindness
"While 71 percent of ... healthcare technology
to alleviate preventable blindness
is not being fulfilled, and millions ...
Gene Therapy Provides Vision to People who Were Nearly Blind
... Trial Supported by the Foundation Fighting blindness
are Published in the New England Journal ... in the 37-year history
of the Foundation Fighting blindness
and the entire history of retinal
degenerative ... therapies and treatments that will reverse blindness
with a variety of retinal degenerative ...
Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology 2009 Meeting
... following trauma or as part of certain diseases of the eye resulting in blindness
in the affected area. In some cases, blindness
or other visual deficits may be permanent, and related to the death of ...
Lions Eye Institute for Transplant & Research, Inc. Launches Multi-Million Dollar, State-of-the-Art Research Institute that Will Advance the Study of Blinding Eye Diseases
... upwards of 3 million Americans, contributes to over 120,000 new cases of blindness
each year and is the leading cause of blindness
among African Americans. LEITR's initial research platforms will explore ...
Alimera Sciences' Iluvien(TM) Phase 3 Studies for DME Pass Final DSMB Review Prior to October Readout
... diabetic retinopathy causes approximately 12,000 to 24,000 new cases of blindness
each year, making diabetes the leading cause of new cases of blindness
in adults aged 20 to 74. Based on published data, Alimera estimates that ...
DSMB Again Supports Continuation of Alimera Sciences' Phase 3 Clinical Trial of Iluvien(TM) for the Treatment of DME
... diabetic retinopathy causes approximately 12,000 to 24,000 new
cases of blindness
each year, making diabetes the leading cause of new
cases of blindness
in adults aged 20 to 74. Based on published data,
Alimera estimates that ...
Gene Therapy Improves Vision in Patients with Congenital Retinal Disease
... It usually begins stealing sight in early
childhood and causes total blindness
during a patient's twenties or
thirties. Currently, there is no treatment ... and Maguire were
part of a team which reported successfully reversing blindness
therapy on dogs affected by the same naturally occurring form ...
ThromboGenics Completes Patient Enrolment in the Phase IIb Trial of Microplasmin in Vitrectomy (MIVI III)
... macular degeneration
(AMD). Diabetic retinopathy is the leading cause of blindness
working-age adults, while AMD is the leading cause of blindness
ThromboGenics is a ...
5-Year Study Published in Diabetologia Demonstrated Long-Term Safety of Lantus(R) Compared to NPH
... in the two treatment groups. This is the longest controlled study ever reported using insulin glargine.
Diabetic retinopathy is a major cause of blindness
in patients with diabetes. It is a progressive disease that results from cellular proliferation within the eye. The stimulation of IGF1 receptors is ...
Potentia Pharmaceuticals' POT-4 Drug Candidate for Age-Related Macular Degeneration Successfully Completes Phase I Clinical Trial - Prepares for Phase II
... on this mechanism of action, POT-4 holds the potential to be effective against both dry and wet AMD.
AMD is the leading cause of blindness
in the elderly of the western world and affects more than 10 million patients in the United States alone. The current standard of care for AMD relies ...
Lake Hospital System Receives $60,000 Grant for Groundbreaking Music Therapy Study
... blood glucose, blood pressure and blood lipids have decreased occurrence of serious complications, including cardiovascular disease, kidney damage, blindness
and lower limb amputations," explained Martin L. Mandel, M.D., F.A.C.E., a Lake Hospital System endocrinologist who is serving as the study's medical ...
ThromboGenics Completes Patient Enrolment for Phase II Trial of Microplasmin for the Treatment of Diabetic Macular Edema (MIVI II DME)
... 6 months follow-up, and to be presented towards the end
Diabetic retinopathy is a major cause of visual loss and the leading
cause of blindness
in patients aged 20-60. Diabetic Macular Edema (DME) is a
condition where swelling of the retina occurs in patients with diabetic
retinopathy, due to ...
ESBATech's Antibody Fragment Enters Phase Ib/IIa in Ophthalmology
... changes in the lens structure. Cataracts are the leading cause of vision loss in adults that are 55 and older and are the leading cause of blindness
worldwide. By age 65, about half of the human population has a cataract, and by age 75, almost everyone has a cataract. Surgery is the only effective ...
Durezol(TM) in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Treatments for Leading Causes of Blindness to Be Presented
... available in Europe for
the treatment of ocular viral infections for more than 10 years.
Herpes simplex keratitis is the leading cause of corneal blindness
the US, with 20,000 new primary cases of diagnosed each year and an
additional 28,000 cases of recurrence each year. The risk of ...
Sirion Therapeutics Announces Positive Pivotal Uveitis Data for Durezol(TM)
... of the middle three layers of the eye: iris,
choroid, and ciliary body. In the US it is responsible for an estimated
30,000 new cases of legal blindness
each year and up to 15% of all cases of
blindness. It affects 0.2% of the population in industrial nations, with as
much as 10 times that prevalence ...
Potentia Pharmaceuticals Announces Positive Safety Data and Study Expansion in Phase I Trial for Lead Drug Candidate POT-4
... information gained from the
extension of the study, to the initiation of Phase II trials in the
AMD is the leading cause of blindness
in the elderly of the western
world and affects more than 10 million patients in the United States alone.
The current standard of care for AMD relies ...
Quark Pharmaceuticals Announces First RNAi Drug Candidate Having a Novel, Proprietary Structure Covered by Quark Intellectual Property
... Data Validates Neuroprotective Effect of Quark's New RNAi Product on
Dying Retinal Ganglion Cells, a Cause of blindness
FREMONT, Calif., Sept. 25 /PRNewswire/ -- Quark Pharmaceuticals, Inc.,
a development-stage pharmaceutical company discovering and ...
FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months
... and increased eye pressure (glaucoma). Call your doctor
immediately if you have any decrease in vision or eye pain. These problems
can lead to blindness
if not treated right away.
More common side effects are tingling in arms and legs, loss of
appetite, tiredness, nausea, diarrhea, taste change and ...
'Snapshots' of Eyes Could Serve as Early Warning of Diabetes or Diabetic Eye Disease, U-M Researchers Report
... 4.1 million people over the age of 40 suffer from
diabetic retinopathy, an eye-related complication of diabetes that is the
leading cause of blindness
among working-age adults.
Twelve individuals in the study were known to have diabetic
retinopathy, a disease in which blood vessels in the eye are ...
MultiVu Video Feed: Large, Long-Term Veterans Affairs Diabetes Trial (VADT) Reveals Important Cardiovascular Safety News on AVANDIA
... the benefits of long-term blood sugar control
on other serious and potentially life-threatening complications of
diabetes, such as kidney failure, blindness
and amputation. VADT is an
independent study sponsored by the Department of Veterans Affairs.
SOUNDBITES: -- Dr. Farhad Zangeneh, MD, FACP, ...
Large, Long-Term Veterans Affairs Diabetes Trial (VADT) Reveals Important Cardiovascular Safety News on AVANDIA(R)
... the benefits of long-term blood sugar control on other serious and
potentially life-threatening complications of diabetes, such as kidney
In VADT, the patient population was considered at higher risk for CV
disease since more than 40% had prior CV events. Further, ...
Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
... program evaluating VEGF Trap-Eye for the treatment of the
neovascular form of Age-related Macular Degeneration (wet AMD), a leading
cause of blindness
VIEW 2 (VEGF Trap-Eye: Investigation of Efficacy and Safety in Wet AMD)
will enroll approximately 1,200 patients in up to 200 centers in ...
MacuSight(TM) Announces Positive Preliminary Results From Phase 1 Study of Sirolimus in Wet Age-Related Macular Degeneration
... tasks including reading and driving. AMD occurs in both
wet and dry forms, with the wet form accounting for the vast majority of
cases of AMD-related blindness
and progressing much more rapidly than dry.
It is presently estimated that wet AMD affects approximately two
million Americans. Growing at an ...
Ellex 2RT Study Demonstrates Clinical Efficacy in Treatment of Diabetic Macular Edema
... the central retina. This results
in a deterioration of sight over time. ABOUT DIABETIC RETINOPATHY Diabetic retinopathy is the leading cause of blindness
in American and
European adults. It is caused by changes in the blood vessels of the
retina. The U.S. Food and Drug Administration estimates that ...
Enrollment Complete in Pivotal Phase 3 Trial of Medidur(TM) FA for Diabetic Macular Edema
pSivida Limited Managing Director, Dr Paul Ashton. Diabetic retinopathy (DR), a complication of diabetes mellitus, is the
leading cause of blindness
in the working-age population of developed
countries. At any time during progression of diabetic retinopathy, patients
can develop DME which involves ...
Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for Insulin Nasal Spray to Treat Diabetes
... Type 2 diabetes accounts for an estimated 90
to 95 percent of all cases. Complications can include cardiovascular
disease, kidney disease, blindness
and diseases of the central nervous
system. Injectable insulin has been used to treat diabetes since the early
1920s and continues to be the ...
VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual
Wet AMD is the leading cause of blindness
for people over the age
of 65 in the U.S. and ... spots in central vision,
and it can account for blindness
in wet AMD patients.
Diabetic ... vessels of the retina. A leading cause of blindness
younger adults (under 50), DME occurs when ...
Positive Interim Phase 2 Data Reported for VEGF Trap-Eye in
Age-Related Macular Degeneration
... 90% of AMD-related blindness. Wet AMD is
the leading cause of blindness
for people over the age of 65 in the
U.S. and Europe.
Macular ... of the retina creating blind spots in central vision
and can account for blindness
in wet AMD patients.
About Regeneron Pharmaceuticals
Regeneron is a ...
Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of
Blindness in Premature Infants
... growth factor binding protein-3
(IGFBP-3) in the prevention of blindness
among premature infants.
IGFBP-3 is a key component of Insmed's lead drug ... development of the small blood vessels in the back of the eye,
leading to blindness
in severe cases. A Phase I clinical study
investigating IPLEX(TM) as a ...
Lux Biosciences' Investigational Therapy for Uveitis, LX211, is
Subject of Two Presentations at Key Ophthalmology Meeting, ARVO
under-recognized medical condition that causes vision impairment,
ocular pain, and loss of vision. Experts estimate that 10% of new
U.S. cases of blindness
result from this disease. Approximately
300,000 people suffer from uveitis in the United States alone, the
majority of whom are affected by anterior ...
Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic
Drug to Treat Viral Eye Infection
... product has the potential to advance medical treatment
of herpes simplex keratitis in the U.S. Herpes simplex keratitis is
a leading cause of corneal blindness
in the United States."
According to data published in the journal Archives of
Ophthalmology, herpes simplex keratitis affects ...
Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology
Shown to Significantly Lower Instances of Severe Retinopathy of
Prematurity in Extremely Low Birth Weight Infants
... low birth weight (ELBW) infants developing retinopathy of
prematurity (ROP) by 40%.(1) One of the most common causes of
visual impairment and blindness
in premature infants, ROP has been
shown to be exacerbated by hyperoxia caused by the excessively high
levels of supplemental oxygen often used to ...
Vision Deficit in Retinitis Pigmentosa Mice Corrected with DNA
... of Oklahoma and the Foundation
Copernicus Therapeutics, Inc., a privately held ...
The urgent mission of the Foundation Fighting blindness
drive the research that will provide ... President Public Affairs
Foundation Fighting blindness
David Harrison, 410-804-1728
Media Contact ...